TSS
FBIO icon

Two Sigma Securities’s Fortress Biotech FBIO Stock Holding History

Two Sigma Securities’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,744
Closed -$69K – 1938
2026
Q1 		$69K Buy
+24,744
New +$84.1K 0.01% 1221
2025
Q4 		– Sell
-30,474
Closed -$113K – 1644
2025
Q3 		$113K Buy
30,474
+16,839
+123% +$42.6K 0.02% 894
2025
Q2 		$25.4K Buy
+13,635
New +$23.6K ﹤0.01% 1172
2023
Q2 		– Sell
-2,413
Closed -$29.7K – 2947
2023
Q1 		$29.7K Buy
+2,413
New +$28.7K ﹤0.01% 2319
2021
Q4 		– Sell
-675
Closed -$33K – 1698
2021
Q3 		$33K Buy
+675
New +$33K ﹤0.01% 1422
2017
Q4 		– Sell
-1,371
Closed -$91K – 1803
2017
Q3 		$91K Buy
+1,371
New +$92.4K 0.01% 684

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Two Sigma Securities's FBIO Position: Q2 2026 in Review

Two Sigma Securities sold out of Fortress Biotech (FBIO) in Q2 2026, closing a stake of 24,744 shares — an estimated $69K sold.

Two Sigma Securities first reported a position in FBIO in Q3 2017 and held it in 6 quarters. The position peaked at $113K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Two Sigma Securities reported no remaining Fortress Biotech position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 24,744 Fortress Biotech shares in Q2 2026, an estimated $69K.
  • Two Sigma Securities first reported a position in Fortress Biotech in Q3 2017 and held it in 6 quarters.
  • Two Sigma Securities's Fortress Biotech position peaked at $113K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.